David H. Watson - 23 Dec 2024 Form 4 Insider Report for ARGAN INC (AGX)

Role: PRESIDENT AND CEO, Director
Signature: /s/ David H. Watson
Issuer symbol: AGX
Transactions as of: 23 Dec 2024
Net transactions value: -$69,945
Form type: 4
Filing time: 21 Apr 2025, 16:41:19 UTC
Previous filing: 20 Dec 2024
Next filing: 11 Jun 2025
SEC: View on sec.gov

Quoteable Key Fact

"David H. Watson filed Form 4 for ARGAN INC (AGX) on 21 Apr 2025."

Quick Takeaways

This page summarizes David H. Watson's Form 4 filing for ARGAN INC (AGX).
13 reported transactions and 8 derivative rows are listed below.
Filing timestamp: 21 Apr 2025, 16:41.

What Changed

Previous filing in this sequence was filed on 20 Dec 2024.
Current net transaction value: -$69,945.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGX	Common Stock	Sale	$69,945	-500	-100%	$139.89	0	23 Dec 2024	Held in The David and Laura Watson Foundation
transaction	AGX	Common Stock	Options Exercise	$0	+1,856	+3.7%	$0.000000	52,647	16 Apr 2025	Direct	F1
transaction	AGX	Common Stock	Options Exercise	$0	+2,286	+4.3%	$0.000000	54,933	17 Apr 2025	Direct	F2
transaction	AGX	Common Stock	Options Exercise	$0	+1,958	+3.6%	$0.000000	56,891	18 Apr 2025	Direct	F3
transaction	AGX	Common Stock	Options Exercise	$0	+11,745	+21%	$0.000000	68,636	18 Apr 2025	Direct	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGX	Time-Based Restricted Stock Units	Options Exercise	$0	-3,333	-16%	$0.000000	18,001	16 Apr 2025	Common Stock	3,333	$0.000000	Direct	F1
transaction	AGX	Time-Based Restricted Stock Units	Award	$0	+4,000	+22%	$0.000000	22,001	16 Apr 2025	Common Stock	4,000	$0.000000	Direct	F5
transaction	AGX	Option to Purchase Common Stock	Award	$0	+2,000	+18%	$0.000000	13,334	16 Apr 2025	Common Stock	2,000	$148.72	Direct	F6
transaction	AGX	Performance-Based Restricted Stock Units	Award	$0	+3,000	+16%	$0.000000	22,000	16 Apr 2025	Common Stock	3,000	$0.000000	Direct	F7
transaction	AGX	Earnings Per Share Performance-Based Restricted Stock Units	Award	$0	+7,500	+42%	$0.000000	25,500	16 Apr 2025	Common Stock	7,500	$0.000000	Direct	F8
transaction	AGX	Time-Based Restricted Stock Units	Options Exercise	$0	-4,000	-18%	$0.000000	18,001	17 Apr 2025	Common Stock	4,000	$0.000000	Direct	F2
transaction	AGX	Time-Based Restricted Stock Units	Options Exercise	$0	-3,334	-19%	$0.000000	14,667	18 Apr 2025	Common Stock	3,334	$0.000000	Direct	F3
transaction	AGX	Performance-Based Restricted Stock Units	Options Exercise	$0	-10,000	-45%	$0.000000	12,000	18 Apr 2025	Common Stock	10,000	$0.000000	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2025.
F2	Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2025.
F3	Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 18, 2022, 3,334 shares of Common Stock became issuable to the Reporting Person on April 18, 2025.
F4	Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 18, 2022, 20,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 18, 2025. The target number of shares was 10,000.
F5	On April 16, 2025 the Reporting Person was granted TRSUs covering 4,000 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/16/2026.
F6	On April 16, 2025, the Reporting Person received 10-year options to purchase 2,000 shares of the Issuer's common stock with an exercise price of $148.72 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/16/2026.
F7	On April 16, 2025, the Reporting Person was granted PRSUs in the target number of 3,000 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2025 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 3,000 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.
F8	On April 16, 2025, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 7,500 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2026, 2027 and 2028 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2023, 2024 and 2025. The pay-out ratio of the target number of 7,500 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.